BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24048883)

  • 1. Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
    Hashimoto T; Yoshioka K; Gondo T; Ozu C; Horiguchi Y; Namiki K; Ohno Y; Ohori M; Nakashima J; Tachibana M
    Int J Clin Oncol; 2014 Aug; 19(4):702-7. PubMed ID: 24048883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
    Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
    Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
    Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
    BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.
    Wang L; Wang B; Ai Q; Zhang Y; Lv X; Li H; Ma X; Zhang X
    Int Urol Nephrol; 2017 Jun; 49(6):995-1005. PubMed ID: 28238148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
    Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
    Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve-Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases.
    Thompson JE; Egger S; Böhm M; Siriwardana AR; Haynes AM; Matthews J; Scheltema MJ; Stricker PD
    Eur Urol; 2018 May; 73(5):664-671. PubMed ID: 29273404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.
    Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
    Asian J Androl; 2016; 18(3):480-4. PubMed ID: 26178393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
    Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
    Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
    Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
    BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
    Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
    BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
    Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
    Eur Urol; 2012 Nov; 62(5):768-74. PubMed ID: 22633365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
    Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
    Hirasawa Y; Ohori M; Sugihara T; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Yoshioka K; Nakashima J; Tachibana M; Ohno Y
    Jpn J Clin Oncol; 2017 Nov; 47(11):1083-1089. PubMed ID: 28973504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
    Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
    Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.